All are true about rabolazine except
Refer CMDT 2014/347 Ranolazine is the first new anti anginal drug to be approved by the FDA in many years and is approved as treatment for first line chronic angina Ranolazine has no effect on hea rate and blood pressure It is safe to use in erectile dysfunction drug It also decreases the occurrence of atrial fibrillation and results in small decrease in haemoglobin It can cause QT prolongation
It causes hypotension
It is recommended as first-line treatment for angina
It improve glycemic control
It is not indicated for acute attack of angina
Cardiovascular system